SWOT Analysis for Structure Therapeutics Inc - ADR

Relative Outperformance versus Industry over 1 Week
Significant (over 30%) distance from 52 week high
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Companies with Low Debt
Stock with Low PE (PE < = 10)
Volume Shockers

Stocks with Quarter Change % less than Industry
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Highest fall from 52 Week High
Top Losers
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Annual net profit declining for last 2 years
Weak Momentum: Price below Short, Medium and Long Term Averages
Declining profits every quarter for the past 3 quarters
RSI indicating price weakness
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter